Dependence of low-frequency sonophoresis on ultrasound parameters; distance of the horn and intensity

被引:64
作者
Terahara, T
Mitragotri, S
Kost, J
Langer, R
机构
[1] MIT, Dept Chem Engn, Cambridge, MA 02139 USA
[2] Hisamitsu Pharmaceut Co Inc, Tsukuba, Ibaraki 3050856, Japan
[3] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA
[4] Ben Gurion Univ Negev, Dept Chem Engn, IL-84105 Beer Sheva, Israel
关键词
sonophoresis; cavitation; transdermal; drug delivery;
D O I
10.1016/S0378-5173(01)00981-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Sonophoresis at a frequency of 20 kHz has been shown to enhance transdermal drug delivery, a phenomenon referred to as low-frequency sonophoresis. This study provides an investigation of the dependence of low-frequency sonophoresis on various ultrasound parameters, including the distance of the horn from the skin, intensity, and frequency, We performed in vitro experiments with full thickness pig skin to measure enhancements of skin conductivity and drug permeability. Ultrasound was applied to pretreat the skin using a sonicator operating at a frequency of either 20 or 40 kHz. We also measured pitting of aluminum foil to measure cavitation, which is the principal mechanism of low-frequency sonophoresis. The skin conductivity enhancement was found to be inversely proportional to the distance of the horn from the skin. As the intensity increased, skin conductivity enhancement also increased up to a certain threshold. and then dropped off. The intensities (I-max) at which maximum enhancement occur are about 14 W/cm(2) for 20 kHz and 17 W/cm(2) for 40 kHz. These findings may be useful in optimizing low-frequency sonophoresis. Overall, the dependence of transport on ultrasound parameters is similar to that of aluminum foil pitting. These results support the role of cavitation in low-frequency sonophoresis. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 22 条
[1]   SONOPHORESIS .2. EXAMINATION OF THE MECHANISM(S) OF ULTRASOUND-ENHANCED TRANSDERMAL DRUG DELIVERY [J].
BOMMANNAN, D ;
MENON, GK ;
OKUYAMA, H ;
ELIAS, PM ;
GUY, RH .
PHARMACEUTICAL RESEARCH, 1992, 9 (08) :1043-1047
[2]   SONOPHORESIS .1. THE USE OF HIGH-FREQUENCY ULTRASOUND TO ENHANCE TRANSDERMAL DRUG DELIVERY [J].
BOMMANNAN, D ;
OKUYAMA, H ;
STAUFFER, P ;
GUY, RH .
PHARMACEUTICAL RESEARCH, 1992, 9 (04) :559-564
[3]  
BRONAUGH RL, 1989, PERCUTANEOUS ABSORPT, P1
[4]   ANALYSIS OF ENHANCED TRANSDERMAL TRANSPORT BY SKIN ELECTROPORATION [J].
EDWARDS, DA ;
PRAUSNITZ, MR ;
LANGER, R ;
WEAVER, JC .
JOURNAL OF CONTROLLED RELEASE, 1995, 34 (03) :211-221
[5]  
Frederick J. R., 1980, ULTRASOUND ENG
[6]   FREQUENCY DEPENDENCE OF ULTRASONIC CAVITATION [J].
GAERTNER, W .
JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA, 1954, 26 (06) :977-980
[7]  
GREEN PG, 1993, PHARM SKIN PENETRATI, P311
[8]  
Kinsler L. E., 2000, FUNDAMENTALS ACOUSTI
[9]   EFFECT OF ULTRASOUND ON TRANSDERMAL DRUG DELIVERY TO RATS AND GUINEA-PIGS [J].
LEVY, D ;
KOST, J ;
MESHULAM, Y ;
LANGER, R .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (06) :2074-2078
[10]   Non-invasive assessment and control of ultrasound-mediated membrane permeabilization [J].
Liu, J ;
Lewis, TN ;
Prausnitz, MR .
PHARMACEUTICAL RESEARCH, 1998, 15 (06) :918-924